Urinary tract infections (UTIs) affect millions of women annually and rank as the second most prevalent infection nationwide. In response to this widespread issue, companies such as Uqora are developing a diverse range of innovative products aimed at combating UTIs. They have initiated clinical trials to assess the efficacy of a new supplement designed to address this health concern.
The Purpose of the Trial
The Uqora trial, titled “Uqora Supplements in Women With UTIs,” commenced in August 2019, with results expected in January 2021. This virtual study examines the effectiveness of a daily dietary supplement from Uqora aimed at managing urinary tract infections (UTIs). Participants are divided into two groups: the control group, which receives a placebo drink mix and capsules, and the experimental group, which is given the Uqora drink mix and capsules. Each participant will receive supplies for a duration of 180 days.
This is a blind trial so participants won’t know if they are receiving the placebo or Uqora product. This dosage is enough to last about six months. During the test, each person in the study will take their supplements, track their occurrence of UTI, and then report on them after the test period is over. The working hypothesis is those who take the products by Uqora will show a heavier decrease of UTIs than those taking the placebo.
Participants in the study are requested to consume cranberry juice or extract to maintain hydration, as this factor may affect UTI rates. Each individual will monitor their own hydration levels. Additionally, subjects are required to maintain a weekly diary, which involves logging into an online account to complete a straightforward questionnaire.
The Criteria for the Study
The research involved 360 women aged 18 and above, all of whom had experienced a minimum of two urinary tract infections (UTIs) in the last six months. Participants were required to be in good health, free from any chronic illnesses. Additionally, they needed to be able to swallow pills. Those with conditions such as diabetes, chronic kidney stones, multiple sclerosis, or who used a catheter or wheelchair were not eligible. Pregnant individuals and those currently using Uqora products for UTIs were also excluded from the study.
Why Uqora is Taking This Step
Uqora was founded by Jenna Ryan. Jenna suffered multiple UTIs throughout her life – as many as eight a year. After being told that there was little to do to stop them from reoccurring, she founded Uqora as a way of researching and creating high-quality UTI prevention methods.
Uqora has helped over 50,000 women with their products. Each product has slightly different purposes and goals, such as flushing out new bacteria, protecting those who are sexually active, and helping those who are not. Uqora ‘s commitment to this treatment method has helped to raise the bar for the industry and fuel studies like these.